Summit Therapeutics Inc.
SMMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$231,793 | -$565,708 | -$62,913 | -$61,203 |
| Dep. & Amort. | $42 | -$986 | -$2,941 | $22 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $478,784 | $11,096 | $11,015 |
| Change in WC | $8,008 | $21,405 | -$6,186 | -$951 |
| Other Non-Cash | $128,724 | -$239 | -$224 | $2,444 |
| Operating Cash Flow | -$95,019 | -$66,744 | -$61,168 | -$48,673 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$71 | -$13 | -$422 | -$14 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$149,488 |
| Inv. Sales/Matur. | -$1,214 | $150,808 | $160,532 | $232,984 |
| Other Inv. Act. | $0 | $13 | $0 | $0 |
| Investing Cash Flow | -$1,286 | $150,808 | $160,110 | $83,482 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$24,500 |
| Stock Issued | $34,660 | $2,520 | $7,677 | -$105 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$298 | $0 | $993 |
| Financing Cash Flow | $34,660 | $2,222 | $7,677 | -$23,612 |
| Forex Effect | $2,329 | $61 | $38 | -$108 |
| Net Chg. in Cash | -$59,316 | $86,347 | $106,657 | $11,089 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $298,191 | $211,844 | $105,187 | $94,098 |
| End Cash | $238,875 | $298,191 | $211,844 | $105,187 |
| Free Cash Flow | -$95,091 | -$66,744 | -$61,590 | -$48,687 |